Scientists at the University of British Columbia have achieved the first successful human trial converting a kidney from blood type A to the universal type O using specialized enzymes. Published in Nature Biomedical Engineering, the approach changes the organ itself to reduce immune rejection, potentially transforming transplantation by expanding donor compatibility and reducing wait times. This advance is the culmination of over a decade of enzyme development targeting blood type-defining sugars.